Insider Trading activities of Apellis Pharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Apellis Pharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Apellis Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Apellis Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is APLS. The reporting company's CIK number is 1492422.
The total value of stock buying since 2005 is $29,894,989.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $128,865.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Apellis Pharmaceuticals, Inc. (APLS).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-05 2,935 $59,785 0 $0 624 $1,666
2018-04 0 $0 0 $0 8,500 $27,200
2018-02 0 $0 0 $0 38,610 $99,999
2017-11 2,131,086 $29,835,204 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Apellis Pharmaceuticals, Inc. insiders (APLS)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-05-29 Watson David O. (General Counsel) Option Ex 624 2.67 1,666
2018-05-24 Scheibler Lukas (See Remarks) Buy 2,935 20.37 59,785
2018-04-11 Grossi Federico (See Remarks) Option Ex 8,500 3.20 27,200
2018-02-20 Axon Steven (Chief Business Officer) Option Ex 38,610 2.59 99,999
2017-11-13 Venbio Global Strategic Fund Ii L.p. (10% Owner) Buy 127,515 14.00 1,785,210
2017-11-13 Morningside Venture Investments Ltd (10% Owner) Buy 575,000 14.00 8,050,000
2017-11-13 Hillhouse Capital Management, Ltd. Buy 1,428,571 14.00 19,999,994

Insider trading activities including stock purchases, stock sales, and option exercises of APLS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Apellis Pharmaceuticals, Inc. (symbol APLS, CIK number 1492422) see the Securities and Exchange Commission (SEC) website.